Skip Navigation

HIV/AIDS

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Grants Awarded (under RFAs and PAs only)

For information on any of the grants listed below, please use the NIH Research Portfolio Online Reporting Tools Expenditures and Results (REPORTER) system. REPORTER is an electronic tool that allows users to search for information on NIH-funded research projects.

Targeting Persistent HIV Reservoirs (TaPHIR):

  • Persistent virus reservoirs in SIV-infected macaques, Mirko Paiardini
  • Targeting the persistent HIV-1 viral reservoir using engineered T cells, James Riley
  • Synthetic molecular sensors to target latently infected cells for HIV eradication, Christopher Woelk
  • Specific Killing of latently HIV-1-infected cells after provirus reactivation, Qigui Yu

Basic Research on HIV Persistence (PA-AI-09-152) 

  • HIV Infection of Hematopoietic Progenitor Cells, Kathleen Collins,
  • HIV-1 evolution in the female genital tract and trafficking to the blood, Lisa Frenkel,
  • Identification and eradication of HIV tissue reservoirs in a relevant animal model, Binhua Ling
  • A Microengraving Technology for the Study of Latently HIV-infected Primary Cells, Xu Yu
  • Targeting HIV Reservoirs in vitro and in vivo, Jerome Zack
  • Tat cofactors and control of HIV-1 latency, Qiang Zhou

Martin Delaney Collaboratory: Towards an HIV Cure (RFA-AI-10-009)  

  • Targeted Modification of Host and Proviral DNA to Treat Latent HIV Infection, Keith Jerome and Hans-Peter Kiem
  • Martin Delaney Collaboratory to Eradicate HIV-1 Infection, David Margolis
  • DARE: Delaney AIDS Research Enterprise to Find a Cure; Steven Deeks, J. Michael McCune, and Rafick Sekaly

For current information on Collaboratory research, visit the following websites:

Beyond HAART:  Innovative Therapies to Control HIV-1 (RFA-AI-11-012)

  • A Gene Therapeutic Approach to Stable Suppression of HIV-1 ReplicationMichael Farzan
  • RNA directed silencing and excision of HIV-1 and CCR5, Kevin Morris

Last Updated April 11, 2013

Last Reviewed April 11, 2013